Trademark Overview
On Friday, February 14, 2025, a trademark application was filed for RETIFLU with the United States Patent and Trademark Office. The USPTO has given the RETIFLU trademark a serial number of 99041341. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, February 18, 2025. The RETIFLU trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical anti-allergic preparations and substances; Biological preparations for use in cell cultures for medical purposes; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Antivirals; Pharmaceutical antitussive-cold preparations; Preparations for treating colds; Adjuvants for medical purposes; Pharmaceutical preparations, namely, antivirals; Biochemical reagents for medical or veterinary purposes; Therapeutic pharmaceutical for the treatment of flu or cold; Pharmaceutical preparations for treating chemical imbalances; Chemical preparations for pharmaceutical or medical purposes, namely, for treatment of flu and cold; Chemical reagents for medical use; Antibacterial substances for medical purposes; Medical preparations for the treatment of flu and cold